HomeMDGL • NASDAQ
add
Madrigal Pharmaceuticals Inc
Previous close
$235.06
Year range
$119.76 - $301.00
Market cap
5.01B USD
Avg Volume
424.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 152.04M | 94.08% |
Net income | -147.54M | -91.87% |
Net profit margin | — | — |
Earnings per share | -7.38 | -74.47% |
EBITDA | -151.87M | -94.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.06B | 221.44% |
Total assets | 1.08B | 225.55% |
Total liabilities | 231.52M | 26.99% |
Total equity | 850.76M | — |
Shares outstanding | 21.31M | — |
Price to book | 5.72 | — |
Return on assets | -44.12% | — |
Return on capital | -50.98% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -147.54M | -91.87% |
Cash from operations | -149.16M | -77.43% |
Cash from investing | 98.05M | 152.47% |
Cash from financing | 573.71M | 988.83% |
Net change in cash | 522.60M | 339.46% |
Free cash flow | -93.01M | -67.72% |
About
Founded
2011
Headquarters
Website
Employees
376